Chargement en cours...
HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes
T-cell-based immunotherapies are promising treatments for cancer patients. Although durable responses can be achieved in some patients, many patients fail to respond to these therapies, underscoring the need for improvement with combination therapies. From a screen of 850 bioactive compounds, we ide...
Enregistré dans:
Publié dans: | Nat Commun |
---|---|
Auteurs principaux: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artigo |
Langue: | Inglês |
Publié: |
Nature Publishing Group UK
2017
|
Sujets: | |
Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5587668/ https://ncbi.nlm.nih.gov/pubmed/28878208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-017-00449-z |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|